Senior VP, Corporate Strategy and Business Development
Steven is a seasoned business development professional who brings 15 years of experience and has executed over $20 billion in aggregate deal value. He has worked at large-cap pharmaceutical companies and at biotechs across various therapeutic areas. Prior to SciNeuro, he held business development, strategy, and finance roles of increasing responsibility at Clover Biopharmaceuticals, AMAG Pharmaceuticals, Radius Health, Shire, and Novartis. Steven began his career as an investment banker and was most recently in Bank of America Merrill Lynch’s global healthcare group where he provided M&A advisory and capital raise services for biopharmaceutical clients. Steven received his B.A. in Physics from U.C. Berkeley and an M.B.A. from Indiana University.